Filing Details
- Accession Number:
- 0001209191-17-054232
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-28 14:45:12
- Reporting Period:
- 2017-09-27
- Accepted Time:
- 2017-09-28 14:45:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647234 | Mostafa Kamal | 15950 North 76Th Street Suite 200 Scottsdale AZ 85260 | Ceo, Magellan Rx Management | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2017-09-27 | 11,819 | $60.55 | 11,819 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2017-09-27 | 7,307 | $64.87 | 19,126 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Disposition | 2017-09-27 | 18,526 | $85.31 | 600 | No | 4 | S | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Disposition | 2017-09-27 | 600 | $86.06 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-27 | 11,819 | $0.00 | 11,819 | $60.55 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-27 | 7,307 | $0.00 | 7,307 | $64.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,514 | 2025-08-03 | No | 4 | X | Direct | |
| 14,613 | 2026-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $85.00 to $85.975, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $86.00 to $86.125, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Of the 50,000 stock options granted, 33,333 are currently vested and exercisable. The remainder of 16,666 options shall vest on August 3, 2018.
- Not applicable.
- Of the 21,920 stock options granted, 7,307 are currently vested and exercisable. The remainder of 14,613 options shall vest in one half increments on March 3 of 2018 and 2019.
Billionaire Hedge Funds
